Aprogen Medicines Inc. (007460.KS) KSC

448.00

-29(-6.08%)

Updated at February 20 03:30PM

Currency In KRW

Valuation

Market Cap200.5B
Enterprise Value277.04B
P/E Ratio-2.66
PEG Ratio-0.18
Price/Sales Ratio1.09
Price/Book Ratio0.86
Enterprise/Revenue2.27
Enterprise/EBITDA-3.95

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.4
Operating Margin-0.78

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.34

Income Statement

Revenue150.11B
Revenue/Share416.89
Gross Profit34.9B
EBITDA-73.38B
Net Income-58.08B
Diluted EPS-224.79

Balance Sheet

Total Cash124.7B
Total Cash/Share412.28
Total Debt248.05B
Total Debt/Equity1.57
Current Ratio0.99
Book Value Per Share1,614.42

Price History

52-Week Change-41.21
52-Week High938
52-Week Low444
Moving Average 50 Days699.58
Moving Average 200 Days676.58

Statistics

Average Volume5.36M
Shares Outstanding305.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor1667:5000
Last Split DateDecember 28, 2022